Loading...
XSTO
KDEV
Market cap26mUSD
Jul 11, Last price  
0.96SEK
1D
-2.75%
1Q
12.88%
Jan 2017
-84.08%
IPO
-97.58%
Name

Karolinska Development AB

Chart & Performance

D1W1MN
P/E
—
P/S
138.87
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.46%
Rev. gr., 5y
-11.49%
Revenues
2m
-8.74%
2,322,00030,320,00013,895,00010,479,0009,943,0009,940,0005,030,0002,942,0005,360,0002,464,0003,073,0003,384,0002,651,0002,170,0002,300,0002,014,0001,838,000
Net income
-8m
L
-5,767,000-2,641,000-334,584,000-385,673,000-212,852,000197,163,000-375,815,000-1,054,673,000-216,832,000179,595,00030,510,000657,709,000-385,476,000353,847,000-145,038,0005,386,000-8,101,000
CFO
-28m
L+11.23%
-18,005,000-34,165,000-97,324,000-133,437,000-152,645,000-82,027,000-108,387,000-325,023,000-8,994,00011,331,00013,154,000-7,409,000-33,200,00016,701,000-32,534,000-25,021,000-27,830,000
Earnings
Aug 28, 2025

Profile

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
URL
https://www.karolinskadevelopment.com/
IPO date
Apr 15, 2011
Employees
8
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,838
-8.74%
2,014
-12.43%
2,300
5.99%
Cost of revenue
1
Unusual Expense (Income)
NOPBT
1,838
2,014
2,300
NOPBT Margin
100.00%
100.00%
100.00%
Operating Taxes
56,916
Tax Rate
2,474.61%
NOPAT
1,838
2,014
(54,616)
Net income
(8,101)
-250.41%
5,386
-103.71%
(145,038)
-140.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
254,911
BB yield
-57.24%
Debt
Debt current
2,112
3,070
753
Long-term debt
2,112
3,070
753
Deferred revenue
11,569
10,208
Other long-term liabilities
(11,569)
(9,016)
Net debt
(1,229,834)
(1,179,530)
(1,173,104)
Cash flow
Cash from operating activities
(27,830)
(25,021)
(32,534)
CAPEX
Cash from investing activities
(14,369)
(19,982)
(113,808)
Cash from financing activities
(1,063)
(803)
235,022
FCF
7,776
(5,395)
(67,470)
Balance
Cash
53,094
85,272
205,790
Long term investments
1,180,964
1,100,398
968,820
Excess cash
1,233,966
1,185,569
1,174,495
Stockholders' equity
(1,497,180)
(1,489,079)
(1,683,532)
Invested Capital
2,738,015
2,738,973
2,924,374
ROIC
0.07%
0.07%
ROCE
0.15%
0.16%
0.19%
EV
Common stock shares outstanding
269,833
269,833
257,417
Price
0.95
-43.94%
1.70
-1.73%
1.73
-67.48%
Market cap
257,151
-43.94%
458,717
3.01%
445,332
-57.74%
EV
(972,683)
(720,813)
(916,839)
EBITDA
2,835
2,812
2,990
EV/EBITDA
Interest
844
Interest/NOPBT
36.70%